Bone marrow-targetable Green Tea Catechin-Based Micellar Nanocomplex for synergistic therapy of Acute myeloid leukemia.
Bone marrow-targetable Green Tea Catechin-Based Micellar Nanocomplex for synergistic therapy of Acute myeloid leukemia.
复制标题
可触摸骨髓的绿茶儿茶素基胶束纳米胶片,用于急性髓样白血病的协同疗法。
DOI:
10.1186/s12951-022-01683-4
复制
发表时间:
2022-11-16
影响因子:
10.2
通讯作者:
Kurisawa, Motoichi
中科院分区:
文献类型:
--
作者:
Bae, Ki Hyun;Lai, Fritz;Mong, Jamie;Niibori-Nambu, Akiko;Chan, Kiat Hwa;Her, Zhisheng;Osato, Motomi;Tan, Min-Han;Chen, Qingfeng;Kurisawa, Motoichi
Currently available anti-leukemia drugs have shown limited success in the treatment of acute myeloid leukemia (AML) due to their poor access to bone marrow niche supporting leukemic cell proliferation. Herein, we report a bone marrow-targetable green tea catechin-based micellar nanocomplex for synergistic AML therapy. The nanocomplex was found to synergistically amplify the anti-leukemic potency of sorafenib via selective disruption of pro-survival mTOR signaling. In vivo biodistribution study demonstrated about 11-fold greater bone marrow accumulation of the nanocomplex compared to free sorafenib. In AML patient-derived xenograft (AML-PDX) mouse model, administration of the nanocomplex effectively eradicated bone marrow-residing leukemic blasts and improved survival rates without noticeable off-target toxicity. This study may provide insights into the rational design of nanomedicine platforms enabling bone marrow-targeted delivery of therapeutic agents for the treatment of AML and other bone marrow diseases. The online version contains supplementary material available at 10.1186/s12951-022-01683-4.
登录
查看更多内容
影响因子:
14
作者:
Ganesh, Shanthi;Iyer, Arun K.;Morrissey, David V.;Amiji, Mansoor M.
通讯作者:
Amiji, Mansoor M.
影响因子:
2.7
作者:
Cornwall, Scott;Cull, Gavin;Ghassemifar, Reza
通讯作者:
Ghassemifar, Reza
影响因子:
2.3
作者:
Falkowski, M;Schledzewski, K;Goerdt, S
通讯作者:
Goerdt, S
影响因子:
5.8
作者:
Craparo, Emanuela F.;Sardo, Carla;Cavallaro, Gennara
通讯作者:
Cavallaro, Gennara
影响因子:
10.8
作者:
DAVIS, SS;ILLUM, L;DUNN, SE
通讯作者:
DUNN, SE